Alzheimer's Disease Drugs
SKU
MRR-434CCDA051A6
Region
Global
Publication Date
March 2024
Delivery
Immediate
2023
USD 4.30 billion
2030
USD 8.45 billion
2024
USD 4.74 billion
CAGR
10.10%
Alzheimer's Disease Drugs Market by Drug Class (Cholinergic, Combined Drug, Memantine), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) - Global Forecast 2024-2030

[196 Pages Report] The Alzheimer's Disease Drugs Market size was estimated at USD 4.30 billion in 2023 and expected to reach USD 4.74 billion in 2024, at a CAGR 10.10% to reach USD 8.45 billion by 2030.

Alzheimer's Disease Drugs Market
To learn more about this report, request a free sample copy
Alzheimer's Disease Drugs Market - Global Forecast 2024-2030
To learn more about this report, request a free sample copy
FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Alzheimer's Disease Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Alzheimer's Disease Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Alzheimer's Disease Drugs Market, highlighting leading vendors and their innovative profiles. These include AB Science, AC Immune SA, AstraZeneca PLC, Avanir Pharmaceuticals Inc. by Otsuka Pharmaceutical, Inc., Biogen Inc., Corium Inc., Eisai Co., Ltd., Grifols, S.A., H. Lundbeck A/S, Luye Pharma Group, Novartis AG, Siemens Healthineers AG, Sun Pharmaceutical Industries Limited, TauRx Therapeutics Ltd., and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Alzheimer's Disease Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Drug Class
    • Cholinergic
    • Combined Drug
    • Memantine
  • Distribution Channel
    • Hospital Pharmacy
    • Online Pharmacy
    • Retail Pharmacy

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Alzheimer's Disease Drugs Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Alzheimer's Disease Drugs Market?
  3. What are the technology trends and regulatory frameworks in the Alzheimer's Disease Drugs Market?
  4. What is the market share of the leading vendors in the Alzheimer's Disease Drugs Market?
  5. Which modes and strategic moves are suitable for entering the Alzheimer's Disease Drugs Market?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Alzheimer's Disease Drugs Market, by Drug Class
  7. Alzheimer's Disease Drugs Market, by Distribution Channel
  8. Americas Alzheimer's Disease Drugs Market
  9. Asia-Pacific Alzheimer's Disease Drugs Market
  10. Europe, Middle East & Africa Alzheimer's Disease Drugs Market
  11. Competitive Landscape
  12. Competitive Portfolio
Companies Mentioned
  • AB Science
  • AC Immune SA
  • AstraZeneca PLC
  • Avanir Pharmaceuticals Inc. by Otsuka Pharmaceutical, Inc.
  • Biogen Inc.
  • Corium Inc.
  • Eisai Co., Ltd.
  • Grifols, S.A.
  • H. Lundbeck A/S
  • Luye Pharma Group
  • Novartis AG
  • Siemens Healthineers AG
  • Sun Pharmaceutical Industries Limited
  • TauRx Therapeutics Ltd.
  • Teva Pharmaceutical Industries Ltd.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.
Frequently Asked Questions about the Alzheimer's Disease Drugs Market
The Global Alzheimer's Disease Drugs Market size was estimated at USD 4.30 billion in 2023 and expected to reach USD 4.74 billion in 2024.
The Global Alzheimer's Disease Drugs Market to grow USD 8.45 billion by 2030, at a CAGR of 10.10%
Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
We are approaching our 7th anniversary in 2024!
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
Absolutely yes, with the purchase of additional user licenses.
Absolutely yes, so long as the 360iResearch cited correctly.